Shin Nippon Biomedical Laboratories, Ltd.
TSE:2395.T
1227 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 26,450.468 | 25,090.903 | 17,748.482 | 15,110.548 | 14,561.084 | 15,658.678 | 16,600.55 | 17,244.496 | 14,750.072 | 17,835.036 | 16,926.397 | 17,154.051 | 15,273.969 | 17,371.947 | 19,050.317 | 19,540.215 | 19,647.248 | 17,289.403 | 13,805.373 | 12,295.73 |
| Cost of Revenue
| 12,429.261 | 12,044.235 | 8,061.183 | 7,556.144 | 6,945.351 | 9,480.91 | 11,396.418 | 12,884.249 | 12,059.11 | 11,882.596 | 11,178.233 | 12,467.221 | 11,978.127 | 12,149.313 | 12,825.31 | 12,703.067 | 11,958.438 | 10,590.143 | 8,417.016 | 8,261.156 |
| Gross Profit
| 14,021.207 | 13,046.668 | 9,687.299 | 7,554.404 | 7,615.733 | 6,177.768 | 5,204.132 | 4,360.247 | 2,690.962 | 5,952.44 | 5,748.164 | 4,686.83 | 3,295.842 | 5,222.634 | 6,225.007 | 6,837.148 | 7,688.81 | 6,699.26 | 5,388.357 | 4,034.574 |
| Gross Profit Ratio
| 0.53 | 0.52 | 0.546 | 0.5 | 0.523 | 0.395 | 0.313 | 0.253 | 0.182 | 0.334 | 0.34 | 0.273 | 0.216 | 0.301 | 0.327 | 0.35 | 0.391 | 0.387 | 0.39 | 0.328 |
| Reseach & Development Expenses
| 1,741.195 | 683.065 | 425.075 | 392.238 | 400.853 | 339.818 | 518.395 | 600.603 | 815.632 | 739.355 | 747.079 | 577.233 | 979.126 | 699.322 | 699.75 | 652.61 | 706.083 | 1,003.587 | 729.513 | 755.135 |
| General & Administrative Expenses
| 1,931.321 | 1,348.22 | 1,000.617 | 835.079 | 859.319 | 953.431 | 906.253 | 1,017.474 | 1,145.863 | 1,073.095 | 1,070.631 | 1,060.924 | 1,258.038 | 1,248.733 | 1,213.527 | 1,382.688 | 1,356.061 | 1,292.604 | 975.569 | 893.625 |
| Selling & Marketing Expenses
| 1,566.329 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8,117.652 | 1,348.22 | 1,000.617 | 835.079 | 859.319 | 953.431 | 906.253 | 1,017.474 | 1,145.863 | 1,073.095 | 1,070.631 | 1,060.924 | 1,258.038 | 1,248.733 | 1,213.527 | 1,382.688 | 1,356.061 | 1,292.604 | 975.569 | 893.625 |
| Other Expenses
| -8.456 | 15.209 | 191.093 | 211.41 | 119.659 | 97.451 | 38.916 | -69.841 | 168.492 | 162.37 | 170.515 | 194.956 | 486.244 | 389.787 | 542.117 | 229.534 | 176.084 | 29.962 | -20.272 | 14.565 |
| Operating Expenses
| 9,858.847 | 7,801.426 | 5,491.682 | 5,024.862 | 5,387.474 | 5,347.966 | 5,901.596 | 6,152.748 | 6,554.406 | 6,588.733 | 6,471.925 | 6,114.916 | 5,563.091 | 5,301.467 | 5,125.089 | 5,523.168 | 5,146.602 | 4,832.223 | 4,003.352 | 3,759.143 |
| Operating Income
| 4,162.36 | 5,245.233 | 4,195.609 | 2,529.534 | 2,228.251 | 829.795 | -697.471 | -1,792.506 | -3,863.449 | -636.3 | -723.769 | -1,428.091 | -3,048.924 | -843.656 | 343.832 | 463.937 | 1,585.633 | 1,125.776 | 772.202 | -328.969 |
| Operating Income Ratio
| 0.157 | 0.209 | 0.236 | 0.167 | 0.153 | 0.053 | -0.042 | -0.104 | -0.262 | -0.036 | -0.043 | -0.083 | -0.2 | -0.049 | 0.018 | 0.024 | 0.081 | 0.065 | 0.056 | -0.027 |
| Total Other Income Expenses Net
| 2,812.084 | 2,514 | 3,986 | 1,644 | 832 | 890 | -810.529 | 1,027.809 | 7,413.768 | 237.764 | 819.266 | 916.849 | -594.662 | -1,060.102 | -688.872 | -1,114.373 | -1,686.099 | -891.152 | -809.903 | -766.622 |
| Income Before Tax
| 6,974.444 | 7,759.612 | 8,183.311 | 4,175.563 | 3,062.667 | 1,650.701 | -1,507.993 | -764.692 | 3,550.324 | -398.53 | 95.504 | -511.237 | -2,861.911 | -1,138.935 | 411.046 | 199.607 | 856.109 | 975.885 | 575.102 | -491.191 |
| Income Before Tax Ratio
| 0.264 | 0.309 | 0.461 | 0.276 | 0.21 | 0.105 | -0.091 | -0.044 | 0.241 | -0.022 | 0.006 | -0.03 | -0.187 | -0.066 | 0.022 | 0.01 | 0.044 | 0.056 | 0.042 | -0.04 |
| Income Tax Expense
| 1,456.736 | 1,708.903 | 1,016.205 | 497.792 | 414.541 | -308.088 | 2,013.233 | 127.781 | 903.419 | 992.416 | 857.597 | 651.425 | 443.124 | 314.403 | -116.575 | 412.7 | 264.141 | 433.639 | 309.391 | -17.005 |
| Net Income
| 5,531.261 | 6,060.057 | 7,127.629 | 3,661.855 | 2,550.379 | 1,950.307 | -3,555.948 | -915.938 | 2,646.136 | -1,385.737 | -754.991 | -1,152.876 | -3,304.109 | -1,442.021 | 534.529 | -205.549 | 599.874 | 543.769 | 267.412 | -472.444 |
| Net Income Ratio
| 0.209 | 0.242 | 0.402 | 0.242 | 0.175 | 0.125 | -0.214 | -0.053 | 0.179 | -0.078 | -0.045 | -0.067 | -0.216 | -0.083 | 0.028 | -0.011 | 0.031 | 0.031 | 0.019 | -0.038 |
| EPS
| 132.86 | 145.57 | 171.21 | 87.96 | 61.26 | 46.85 | -85.41 | -22.18 | 66.52 | -34.84 | -20.12 | -33.57 | -96.21 | -43.26 | 16.14 | -6.03 | 17.46 | 15.83 | 8.28 | -29.96 |
| EPS Diluted
| 132.86 | 145.57 | 171.21 | 87.96 | 61.26 | 46.85 | -85.41 | -22.18 | 66.52 | -34.84 | -20.12 | -33.57 | -96.21 | -43.26 | 16.14 | -6.03 | 17.46 | 15.83 | 8.28 | -29.96 |
| EBITDA
| 6,030.345 | 10,919.667 | 8,704.704 | 5,017.882 | 4,240.771 | 3,423.153 | 1,170.125 | 525.889 | 3,282.378 | 1,837.444 | 1,770.684 | 1,186.821 | -159.662 | 1,667.362 | 3,473.805 | 3,135.313 | 4,076.802 | 3,253.465 | 2,436.593 | 1,137.362 |
| EBITDA Ratio
| 0.228 | 0.435 | 0.49 | 0.332 | 0.291 | 0.219 | 0.07 | 0.03 | 0.223 | 0.103 | 0.105 | 0.069 | -0.01 | 0.096 | 0.182 | 0.16 | 0.207 | 0.188 | 0.176 | 0.093 |